Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth

Lulu Guan(First Affiliated Hospital of Zhengzhou University), Feng Wang(First Affiliated Hospital of Zhengzhou University)
Frontiers in Pharmacology
April 24, 2023
10.3389/fphar.2023.1141420
Cited by 6

Related Papers

Environmental concentrations of 6PPD and 6PPD-quinone induce hepatic lipid metabolism disorders in male black-spotted frogs
|Journal of Hazardous Materials|2024|73
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study
|European Journal of Cancer|2024|18